Published in Cytokine Growth Factor Rev on June 21, 2013
How the Intricate Interaction among Toll-Like Receptors, Microbiota, and Intestinal Immunity Can Influence Gastrointestinal Pathology. J Immunol Res (2015) 0.94
JAK inhibition using tofacitinib for inflammatory bowel disease treatment: a hub for multiple inflammatory cytokines. Am J Physiol Gastrointest Liver Physiol (2015) 0.93
The Interaction among Microbiota, Immunity, and Genetic and Dietary Factors Is the Condicio Sine Qua Non Celiac Disease Can Develop. J Immunol Res (2015) 0.83
IL-15-dependent balance between Foxp3 and RORγt expression impacts inflammatory bowel disease. Nat Commun (2016) 0.78
The Interactions between Innate Immunity and Microbiota in Gastrointestinal Diseases. J Immunol Res (2015) 0.77
Supplementation of Reduced Gluten Barley Diet with Oral Prolyl Endopeptidase Effectively Abrogates Enteropathy-Associated Changes in Gluten-Sensitive Macaques. Nutrients (2016) 0.76
Gliadin-dependent cytokine production in a bidimensional cellular model of celiac intestinal mucosa. Clin Exp Med (2014) 0.76
The cross-talk between enterocytes and intraepithelial lymphocytes. Mol Cell Pediatr (2016) 0.76
Bortezomib augments lymphocyte stimulatory cytokine signaling in the tumor microenvironment to sustain CD8+T cell antitumor function. Oncotarget (2016) 0.75
Levels of circulating TNF-related apoptosis-inducing ligand in celiac disease. Exp Ther Med (2014) 0.75
Propionibacterium acnes overabundance and natural killer group 2 member D system activation in corpus-dominant lymphocytic gastritis. J Pathol (2016) 0.75
IL-15 temporally reorients IL-10 biased B-1a cells toward IL-12 expression. Cell Mol Immunol (2015) 0.75
The role of "bone immunological niche" for a new pathogenetic paradigm of osteoporosis. Anal Cell Pathol (Amst) (2015) 0.75
Celiac disease: understanding the gluten-free diet. Eur J Nutr (2016) 0.75
Cytokine production profile in intestinal mucosa of paediatric inflammatory bowel disease. PLoS One (2017) 0.75
Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med (2005) 4.57
Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology (2009) 4.16
Liver transplantation in alcoholic patients: impact of an alcohol addiction unit within a liver transplant center. Alcohol Clin Exp Res (2013) 2.84
Acute leukemia in polycythemia vera: an analysis of 1638 patients enrolled in a prospective observational study. Blood (2004) 2.64
Vascular and neoplastic risk in a large cohort of patients with polycythemia vera. J Clin Oncol (2005) 2.50
Management of alcohol dependence in patients with liver disease. CNS Drugs (2013) 2.35
Widespread myocardial inflammation and infarct-related artery patency. Circulation (2004) 2.27
Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development. J Hepatol (2009) 2.14
Reflux symptoms in professional opera choristers. Gastroenterology (2007) 2.03
Dose-response effect of baclofen in reducing daily alcohol intake in alcohol dependence: secondary analysis of a randomized, double-blind, placebo-controlled trial. Alcohol Alcohol (2011) 1.98
Portal vein thrombosis: insight into physiopathology, diagnosis, and treatment. World J Gastroenterol (2010) 1.69
Unexplained iron deficiency anaemia: Is it worthwhile to perform capsule endoscopy? Dig Liver Dis (2010) 1.68
Lack of endoscopic visualization of intestinal villi with the "immersion technique" in overt atrophic celiac disease. Gastrointest Endosc (2003) 1.64
Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication. Am J Gastroenterol (2006) 1.62
Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound. J Hepatol (2013) 1.62
Image-enhanced endoscopy with I-scan technology for the evaluation of duodenal villous patterns. Dig Dis Sci (2012) 1.52
Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study. Am J Gastroenterol (2002) 1.32
The haematocrit and platelet target in polycythemia vera. Br J Haematol (2006) 1.25
Epstein syndrome: another renal disorder with mutations in the nonmuscle myosin heavy chain 9 gene. Hum Genet (2001) 1.15
Biofilm demolition and antibiotic treatment to eradicate resistant Helicobacter pylori: a clinical trial. Clin Gastroenterol Hepatol (2010) 1.11
Faecal calprotectin concentrations in untreated coeliac patients. Scand J Gastroenterol (2007) 1.09
Polymyalgia rheumatica in 2011. Best Pract Res Clin Rheumatol (2012) 1.05
Small intestinal bacterial overgrowth recurrence after antibiotic therapy. Am J Gastroenterol (2008) 1.05
Third-line rescue therapy for Helicobacter pylori infection. World J Gastroenterol (2006) 1.02
Prevention of thrombosis in polycythemia vera and essential thrombocythemia. Haematologica (2008) 1.01
Association between hypothyroidism and small intestinal bacterial overgrowth. J Clin Endocrinol Metab (2007) 1.01
Colon capsule endoscopy: Advantages, limitations and expectations. Which novelties? World J Gastrointest Endosc (2012) 1.00
Increased frequency of Ig heavy-chain HS1,2-A enhancer *2 allele in dermatitis herpetiformis, plaque psoriasis, and psoriatic arthritis. J Invest Dermatol (2008) 0.99
Levofloxacin based regimens for the eradication of Helicobacter pylori. Eur J Gastroenterol Hepatol (2002) 0.99
Prophylaxis against venous thromboembolism in patients with cancer. N Engl J Med (2014) 0.97
Management and treatment of lactose malabsorption. World J Gastroenterol (2006) 0.96
Induction of "antigen silencing" in melanomas by oncostatin M: down-modulation of melanocyte antigen expression. Mol Cancer Res (2003) 0.96
Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility. Biomed Res Int (2013) 0.95
Assessment of systemic inflammation and infective pathogen burden in patients with cardiac syndrome X. Am J Cardiol (2004) 0.94
Cellular mediators of inflammation: tregs and TH17 cells in gastrointestinal diseases. Mediators Inflamm (2010) 0.94
Ipilimumab Adjuvant Therapy in Melanoma. N Engl J Med (2017) 0.94
Reliability of the "immersion technique" during routine upper endoscopy for detection of abnormalities of duodenal villi in patients with dyspepsia. Gastrointest Endosc (2004) 0.93
Virulent strains of Helicobacter pylori and vascular diseases: a meta-analysis. Am Heart J (2006) 0.93
Eradication of small intestinal bacterial overgrowth and oro-cecal transit in diabetics. Hepatogastroenterology (2002) 0.92
Nonalcoholic fatty liver disease is associated with increased GHBP and reduced GH/IGF-I levels. Clin Endocrinol (Oxf) (2012) 0.92
GSH depletion, protein S-glutathionylation and mitochondrial transmembrane potential hyperpolarization are early events in initiation of cell death induced by a mixture of isothiazolinones in HL60 cells. Biochim Biophys Acta (2006) 0.92
'Doctor, treat your patient, not your monitor!' Tremor-induced ECG artefacts mimicking torsades de pointes. BMJ Case Rep (2014) 0.91
High prevalence of celiac disease in patients with lactose intolerance. Digestion (2005) 0.91
Direct visualization of intestinal villi by high-resolution magnifying upper endoscopy: a validation study. Gastrointest Endosc (2004) 0.91
High levels of dual resistance to clarithromycin and metronidazole and in vitro activity of levofloxacin against Helicobacter pylori isolates from patients after failure of therapy. Int J Antimicrob Agents (2004) 0.91
Double-balloon enteroscopy for diagnosis of a Meckel's diverticulum in a patient with GI bleeding of obscure origin. Gastrointest Endosc (2005) 0.91
Increased CD4+CD25+Foxp3+ T cells in peripheral blood of celiac disease patients: correlation with dietary treatment. Hum Immunol (2009) 0.90
Negative capsule endoscopy in patients with obscure gastrointestinal bleeding reliable: recurrence of bleeding on long-term follow-up. World J Gastroenterol (2013) 0.90
Fecal calprotectin concentrations in patients with small intestinal bacterial overgrowth. Dig Dis (2008) 0.90
HCV infection and extrahepatic manifestations. Hepatogastroenterology (2003) 0.90
IL-1β biological treatment of familial Mediterranean fever. Clin Rev Allergy Immunol (2013) 0.89
Differential diagnosis of pulmonary embolism in outpatients with non-specific cardiopulmonary symptoms. Intern Emerg Med (2011) 0.89
Association of laryngeal cancer with previous gastric resection. Ann Surg (2004) 0.89
Fecal microbiota transplantation in inflammatory bowel disease: beyond the excitement. Medicine (Baltimore) (2014) 0.89
Biliary laryngopharyngeal reflux: a new pathological entity. Curr Opin Otolaryngol Head Neck Surg (2006) 0.88
Locally injected Infliximab ameliorates murine DSS colitis: differences in serum and intestinal levels of drug between healthy and colitic mice. Dig Liver Dis (2013) 0.88
Increased expression of T-bet in circulating B cells from a patient with multiple sclerosis and celiac disease. Hum Immunol (2008) 0.88
Clopidogrel-induced neutropenia after coronary stenting: is cilostazol a good alternative? Int J Vasc Med (2011) 0.87
Moderately severe acute pancreatitis associated with riluzole. J Clin Gastroenterol (2014) 0.87
Celiac disease: what's new about it? Dig Dis (2008) 0.87
Tired legs--a gut diagnosis. Lancet (2010) 0.87
Can chronic gastritis cause an increase in fecal calprotectin concentrations? World J Gastroenterol (2010) 0.86
Biochemical and biological aspects of protein thiolation in cells and plasma. Antioxid Redox Signal (2005) 0.86
A case of variant angina in a patient under chronic treatment with sorafenib. Nat Rev Clin Oncol (2010) 0.85
Post-cholecystectomy alkaline reactive gastritis: a randomized trial comparing sucralfate versus rabeprazole or no treatment. Eur J Gastroenterol Hepatol (2003) 0.85
Fecal calprotectin in first-degree relatives of patients with ulcerative colitis. Am J Gastroenterol (2006) 0.85
Allele *1 of HS1.2 enhancer associates with selective IgA deficiency and IgM concentration. J Immunol (2009) 0.85
Gastric surgery as a long-term risk factor for malignant lesions of the larynx. Arch Surg (2003) 0.85
Tissue-infiltrating lymphocytes analysis reveals large modifications of the duodenal "immunological niche" in coeliac disease after gluten-free diet. Clin Transl Gastroenterol (2012) 0.85
Angiogenic impairment of the vascular endothelium: a novel mechanism and potential therapeutic target in muscular dystrophy. Arterioscler Thromb Vasc Biol (2013) 0.85
The water immersion technique is easy to learn for routine use during EGD for duodenal villous evaluation: a single-center 2-year experience. J Clin Gastroenterol (2009) 0.85
Protein-thiol substitution or protein dethiolation by thiol/disulfide exchange reactions: the albumin model. Proteins (2007) 0.84
Rapid detection of clarithromycin resistance in Helicobacter pylori using a PCR-based denaturing HPLC assay. J Antimicrob Chemother (2005) 0.84
Involvement of central immunity in uncomplicated diverticular disease. Scand J Gastroenterol (2009) 0.84
Surgical bleeding after pre-operative unfractionated heparin and low molecular weight heparin for coronary bypass surgery. Haematologica (2007) 0.84
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms. Dig Liver Dis (2012) 0.83
Distinct expression of cyclooxygenase-1 and -2 in the human thymus. Eur J Immunol (2002) 0.83
A structurally driven analysis of thiol reactivity in mammalian albumins. Biopolymers (2010) 0.83
Skeletal muscle wastage in Crohn's disease: a pathway shared with heart failure? Int J Cardiol (2007) 0.83
Autoimmune hemolytic anemia with gel-based immunohematology tests. Am J Clin Pathol (2013) 0.83
Update on triple therapy for eradication of Helicobacter pylori: current status of the art. Clin Exp Gastroenterol (2012) 0.82
Regulation of redox forms of plasma thiols by albumin in multiple sclerosis after fasting and methionine loading test. Amino Acids (2009) 0.82
The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin. Dig Dis (2016) 0.81
Rifaximin-based regimens for eradication of Helicobacter pylori: a pilot study. Dig Dis (2006) 0.81
IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII. J Clin Invest (2015) 0.81